Cargando…
Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation
Autores principales: | Leisman, Daniel E., Deutschman, Clifford S., Legrand, Matthieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186535/ https://www.ncbi.nlm.nih.gov/pubmed/32347323 http://dx.doi.org/10.1007/s00134-020-06059-6 |
Ejemplares similares
-
Intensive care medicine in 2050: the ICU in vivo
por: Ince, Can
Publicado: (2017) -
What is new in non-ventilated ICU-acquired pneumonia?
por: Saied, Wafa Ibn, et al.
Publicado: (2020) -
Antibiotic prophylaxis in the ICU: to be or not to be administered for patients undergoing procedures?
por: Martin-Loeches, Ignacio, et al.
Publicado: (2019) -
What’s new in reducing the impact of tracheostomy on communication and swallowing in the ICU
por: Mills, Claire S., et al.
Publicado: (2023) -
Goal-concordant care in the ICU: a conceptual framework for future research
por: Turnbull, Alison E., et al.
Publicado: (2017)